PHALANX BIOTECH
Update：2026/06/05
Industries
Main Industry
Biotechnology
Main Product/Service
Maternal and Child Health Testing: Provides prenatal and postnatal chromosomal microarray screening, such as CytoOneArray, which can screen for more than 400 genetic disorders in a single test, including chromosomal abnormalities and developmental delays.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.
Founded Year
2025
Unified Business No.
60763646
Status
Active
Total Paid-in
Capital
140,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PHALANX BIOTECH specializes in developing genetic testing platforms, utilizing technologies like microarray chips, next-generation sequencing, and big data analysis.
